stock · yahoo

Olympus Corporation

7733.T

$11.99
0.23 (-1.86%)
polled · warming up

Unten findest du den Live-Kurs für Olympus Corporation (7733.T), einen 1-Jahres-Chart, 8 Indikatoren (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) und einen Vergleichsmodus. Hinzufügen zum Portfolio, auf die Beobachtungsliste setzen oder einen Preisalarm einrichten — alles in einem.

Day
-1.86%
-35.00
Week
+3.44%
+61.50
Month
+17.57%
+276.00
Year
-3.80%
-73.00
Prev close
$12.22
Volume
$11.54K
Market cap
$13.21B
Currency
USD (native JPY)

Financials

52w high
¥2,168
52w low
¥1,302.5
52w change
-3.54%
Day high
¥1,882.5
Day low
¥1,840.5
P/E (TTM)
30.19
Forward P/E
14.7
PEG
3.61
Price / Book
2.5
Beta (5Y)
0.19
Enterprise value
2.12T
EV / Revenue
2.1
EV / EBITDA
10.27
EPS (TTM)
¥61.17
Forward EPS
¥125.64
Dividend yield
1.59%
Dividend rate
¥30
Payout ratio
49.02%
Revenue (TTM)
1.01T
EBITDA
206.79B
Free cash flow
1.49B
Total cash
188.04B
Total debt
239.58B
Debt / Equity
29.5
Current ratio
1.62
Quick ratio
1
Profit margin
6.74%
Gross margin
64.72%
Return on assets
5.87%
Return on equity
8.72%
Shares outstanding
1.1B
Float
1.06B
Sector: HealthcareIndustry: Medical DevicesHQ: Japanwww.olympus.co.jp

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Analyst & Risk

Consensus
Buy
Mean rating2.43 / 5
Analysts13
Next earnings2026-08-07
Strong buy 3Buy 3Hold 7Strong sell 1
Analyst price target
¥1,882.31
Mean target · 13 analysts
+1.9%
upside
Low ¥1,600Now ¥1,847High ¥2,300
Beta (vs S&P 500)
0.19
very stable
52-week change
-3.54%
Debt / Equity
29.5
very high leverage
Current ratio
1.62
Quick ratio
1
ROE
8.72%
ROA
5.87%
PEG ratio
3.61
richly valued
EV / Revenue
2.1
EV / EBITDA
10.27
Revenue growth
8.50%
Earnings growth
-38.70%
EBITDA
206.79B
Free cash flow
1.49B
Total cash
188.04B
Total debt
239.58B
Insider holdings
4.27%
Institutional
62.34%

Live-Diskussion

Anmelden to join the discussion.

  • Noch keine Kommentare. Sei der Erste.